WHO's First Guidelines on GLP-1 Drugs for Obesity
WHO releases first-ever global guidelines for GLP-1 medicines to treat obesity, a chronic disease. Learn about the key recommendations and new mental health warnings from Australia.
WHO releases first-ever global guidelines for GLP-1 medicines to treat obesity, a chronic disease. Learn about the key recommendations and new mental health warnings from Australia.
WHO releases its first global guideline on GLP-1 therapies for obesity, recommending drugs like semaglutide for adults with a BMI over 30. Learn about the impact, safety, and who can benefit.
A new study finds low choline levels in obese young adults may be an early warning for future brain problems like Alzheimer's. Discover the vital nutrient's role and food sources to boost intake.
A 30-year-old Russian fitness trainer died from heart failure after consuming 10,000 calories daily. Learn the deadly risks of rapid weight gain and how to protect your heart.
The 'Ozempets' trend of using human weight-loss drugs like Ozempic on pets is growing. Experts warn of severe risks as these drugs are not approved for animals. Learn safe alternatives.
Delhi High Court permits Dr Reddy's to export generic semaglutide, a major win for Indian drugmakers eyeing the booming anti-obesity market. Read the full analysis.
Eli Lilly reduces Zepbound's starting price to $299 monthly, intensifying its price war with Novo Nordisk's Ozempic and Wegovy. New discounts aim to expand access to blockbuster weight-loss drugs.
Essential UPSC updates: Govt's Sanchar Saathi app directive, GPS spoofing threats, WHO's obesity guidelines, fiscal federalism debate, and India's rare-earth push. Key insights for Prelims & Mains.
A landmark 14-year study reveals your neighbourhood significantly impacts your body weight. Discover how local food environments and walkability shape health outcomes in India and beyond.
Explore how berberine, a traditional Ayurvedic compound, supports weight management, improves insulin sensitivity, and regulates metabolism through scientific mechanisms like AMPK activation. Learn about its safe usage.
Union Minister Pankaj Chaudhary reveals Telangana contributed ₹4.36 lakh crore to central coffers from 2019-2025, receiving ₹3.76 lakh crore back. See the widening gap in recent years.
Dr. Deepak Bhat from Amritsar highlights the dangers of junk food for children, advocating for mindful eating and traditional diets to prevent obesity and chronic diseases. Learn key tips.
Eli Lilly's oral GLP-1 drug Orforglipron offers needle-free weight management with significant results in Phase 3 trials. Discover how this tablet alternative works.
Odisha government mandates oil boards in childcare centers to educate children about hidden fats in snacks. Learn how this initiative tackles rising obesity rates.
A PGI lecture revealed an epidemic of undiagnosed lifestyle diseases in Chandigarh. Over 100 attendees learned how obesity and diabetes are driving heart disease. Act now to protect your health.
Prayagraj Junction emerges as North Central Railway's top revenue station, generating Rs 288.30 crore. Discover how it surpassed Kanpur Central and what this means for passenger facilities.
Groundbreaking UC Riverside research reveals how America's favorite cooking oil contributes to weight gain and metabolic disorders. Learn the science behind soybean oil's impact on your health.
A bariatric surgeon reveals 7 crucial signs that childhood weight issues may indicate serious health problems. Learn to spot early warnings for diabetes, heart issues, and joint problems.
Eli Lilly's daily pill orforglipron shows 12% weight loss in trials, potentially revolutionizing obesity treatment. Could this be the end of injections?
Leading bariatric specialists Dr. Todkar, Dr. Dukkipati & Dr. Garg share crucial insights on managing India's dual health crisis through early intervention & lifestyle changes. Act now for better health!
Bodil Nyboe Andersen, Denmark's pioneering female central bank governor who served from 1990-2005, passed away at 85. She navigated financial crises and broke gender barriers in banking.
Childhood obesity in India surges from 3-4% to 8-9%, driven by lifestyle changes and mental health factors. Dr. Atul Peters reveals how families can reverse this alarming trend through simple changes.
India's pharmaceutical industry is transitioning toward innovative drugs, with multiple companies preparing obesity reduction launches. Discover how PHARMEXCIL is driving this competitive transformation.
A new report reveals a sharp 5-fold increase in obesity in India over 30 years, affecting 1 in 4 adults. Learn about the health risks and what it means for the nation.
New Lancet study reveals 25% of Indians face obesity, costing economy ₹29,000 crore annually. Urgent public health action needed to address this growing crisis.
New OSSI survey reveals insurance barriers prevent timely obesity treatment in India. Learn how policy gaps affect patient care and what needs to change.
PGI Chandigarh warns of a sharp increase in Type 2 diabetes among children and young adults, driven by junk food and sedentary lifestyles. Learn how to prevent it.
Lancet study reveals India's ultra-processed food epidemic with retail sales skyrocketing 40-fold since 2006, driving obesity and diabetes crisis among youth. Experts demand urgent policy reforms.
Discover the top 6 lifestyle diseases affecting Indians, their causes, symptoms, and preventive measures. Learn how to protect your health today!
Novo Nordisk reduces Wegovy's price to $349 and prepares an aggressive launch for its oral weight-loss pill to combat competition from Eli Lilly and expand patient access.